SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis
Open Access
- 10 March 2023
- journal article
- research article
- Published by MDPI AG in Pharmaceuticals
- Vol. 16 (3) , 423
Abstract
The so-far used Ga-68- or F-18-labelled tracers are of a relative short time window in differentiating tumor fibrosis. SPECT applicable imaging probe, 99mTc-HYNIC-FAPI-04, was synthesized and evaluated in tumor cells and animal models of FAP-positive glioma and FAP-negative hepatoma, and then compared with 18F-FDG or 68Ga-FAPI-04 PET/CT. The radio-labeling rate of 99mTc-HYNIC-FAPI-04 was greater than 90%, and the radiochemical purity was >99% after purification with sep-pak C18 column. In vitro cell uptake experiments of 99mTc-HYNIC-FAPI-04 showed good FAP binding specificity, and the cellular uptake significantly decreased when blocked by DOTA-FAPI-04, reflecting the similar targeting mechanism of HYNIC-FAPI-04 and DOTA-FAPI-04. SPECT/CT imaging showed that U87MG tumor was distinguishable and of a high uptake of 99mTc-HYNIC-FAPI-04 (2.67 ± 0.35 %ID/mL at 1.5 h post injection (h P.I.), while tumor signal of FAP-negative HUH-7 was as low as 0.34 ± 0.06 %ID/mL. At 5 h P.I., U87MG tumor was still distinguishable (1.81 ± 0.20 %ID/mL). In comparison, although U87MG tumor was of obvious 68Ga-FAPI-04 uptake and clearly visible at 1 h P.I., the tumorous radioactive signals were fuzzy at 1.5 h P.I. 99mTc-HYNIC-FAPI-04 specifically bound to FAP-positive tumors and qualified with the ability of evaluating tumor fibrosis over longer time windows.Keywords
Funding Information
- Special Foundation for Emerging Interdisciplinary Field Research of Shanghai Municipal Health Commission (2022JC004, 82272040, GH145-22, 2019YPT002, 2020YPT002)
- National Natural Science Foundation of China (2022JC004, 82272040, GH145-22, 2019YPT002, 2020YPT002)
- First Affiliated Hospital of Naval Medical University (Shanghai Changhai Hospital) “Guhai Plan in the 14th Five-Year Plan period” (2022JC004, 82272040, GH145-22, 2019YPT002, 2020YPT002)
- “Discipline Construction Climbing 234 Plan” of Shanghai Changhai Hospital of Naval Medical University (2022JC004, 82272040, GH145-22, 2019YPT002, 2020YPT002)
This publication has 36 references indexed in Scilit:
- Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosisJournal of Nuclear Cardiology, 2015
- Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapyProteomics – Clinical Applications, 2014
- High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosisTumor Biology, 2013
- The role of nuclear medicine in modern therapy of cancerTumor Biology, 2012
- Clinical evaluation of antimicrobial peptide [99mTc/Tricine/HYNIC0]ubiquicidin 29–41 as a human-specific infection imaging agentNuclear Medicine and Biology, 2009
- Comparison of SPECT/CT, SPECT, and Planar Imaging with Single- and Dual-Phase 99mTc-Sestamibi Parathyroid ScintigraphyJournal of Nuclear Medicine, 2007
- Fibroblasts in cancerNature Reviews Cancer, 2006
- 99mTc-Labeling and in Vitro and in Vivo Evaluation of HYNIC- and (Nα-His)Acetic Acid-Modified [d-Glu1]-MinigastrinBioconjugate Chemistry, 2004
- Nuclear medicine in cancer diagnosisThe Lancet, 1999
- Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers.Proceedings of the National Academy of Sciences, 1994